trial

Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia

NCTId NCT00406718
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 197 (actual)
Sponsored by The University of Texas Health Science Center at San Antonio
Primary completion 2013-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
197 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2006-11
Primary completion
2013-07
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Med-eMonitorPharmCAT

Sponsors

The University of Texas Health Science Center at San AntonioLead Sponsor

Investigators

1
Dawn I. Velligan, PhDPrincipal Investigator

Sites

1 total
San Antonio, United States

Facts & assertions

4 sourced
Enrollment
197
Phase
NA
Primary Completion Date
2013-07
Status
COMPLETED
relationships
The graph out of here
drug
Med-eMonitor
drug
PharmCAT
drug
lead_sponsor
The University of Texas Health Science Center at San Antonio
company
indication
Medication Adherence
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
investigator
Dawn I. Velligan, PhD
person